The misuse and overuse of antibiotics have led to the rise of antibiotic-resistant bacteria, posing a significant public health threat. As physicians, we play a crucial role in curbing this trend through the rational use of antibiotics.
Antibiotic resistance occurs when bacteria evolve in response to the use of these medicines. Bacteria, not humans or animals, become antibiotic-resistant. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria.
Rational antibiotic use involves prescribing the right antibiotic, at the right dose, at the right time, and for the right duration. It is essential to only prescribe antibiotics when necessary, and to educate patients on the importance of taking the full course of antibiotics as prescribed, even if they feel better before it is finished.
Diagnostic tests can help determine whether a patient's symptoms are due to a bacterial infection, which can be treated with antibiotics, or a viral infection, which cannot. Rapid diagnostic tests can provide results in about 15-20 minutes.
Antibiotic stewardship programs aim to optimize antibiotic use in order to improve patient outcomes, reduce antibiotic resistance, and decrease unnecessary costs. These programs involve coordinated interventions designed to improve and measure the appropriate use of antibiotic agents.
As physicians, our role in promoting patient health extends beyond individual patient encounters. Through the rational use of antibiotics, we can contribute to the broader public health goal of combating antibiotic resistance. By adhering to the principles of rational antibiotic use, using diagnostic tests appropriately, and participating in antibiotic stewardship programs, we can ensure our patients receive the best possible care while also protecting the effectiveness of antibiotics for future generations.
1.
Trial Supports Ivonescimab and Chemo for NSCLC Survival
2.
Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.
3.
Lymph node transfer reduces arm swelling after breast cancer surgery, study shows
4.
Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.
5.
Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?
1.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
2.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
3.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
4.
Uncovering the Mysteries of the RDW Blood Test
5.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part II
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Navigating the Complexities of Ph Negative ALL - Part XIV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation